Companies similar to KURA ONCOLOGY INC (KURA)
Health Care · NASDAQ
KURA ONCOLOGY INC (KURA)'s closest peers include SYNDAX PHARMACEUTICALS INC (SNDX), Revolution Medicines (RVMD), Gilead Sciences (GILD), NOVARTIS AG (NVS) and Bristol Myers Squibb (BMY). This peer set is drawn from KURA's enriched company profile and is informational only — not financial advice.
Similar companies
-
SYNDAX PHARMACEUTICALS INCSNDXHealth Care
Syndax Pharmaceuticals is a clinical-stage and commercial-stage biotechnology company developing a pipeline of targeted cancer therapies, including approved…
$22.64 (as of 2026-07-21) · market cap $2.0B
-
Revolution MedicinesRVMDHealth Care
A precision oncology biotech in clinical development stages, pursuing targeted cancer therapies with no approved products yet but backed by substantial capital.
$183.29 (as of 2026-07-21) · market cap $38.9B
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$130.28 (as of 2026-07-21) · market cap $161.3B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
Not quite? Describe exactly what you want →
Peers are drawn from KURA's enriched profile (the same similarity signal the chat uses for "companies like KURA"). See the full profile: KURA ONCOLOGY INC (KURA).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.